FDA In Brief
This article was originally published in The Gray Sheet
Executive Summary
August ENT panel meeting: FDA's Ear Nose and Throat Devices Panel will meet Aug. 16 in Gaithersburg, Maryland to discuss and make recommendations on the recently issued implantable middle ear hearing device draft guidance (1"The Gray Sheet" June 17, 2002, p. 11). Topics to be addressed include "appropriate study population, objective measurement techniques for comparison of acoustic hearing aids and middle ear hearing devices and subjective questionnaire development for determining postoperative effectiveness and quality of life outcomes," according to the 2ENT meeting announcement. Requests for formal oral presentations should be submitted to FDA by Aug. 8...
You may also be interested in...
FDA Implantable Middle Ear Draft Guidance Follows Panel Recommendations
Direct comparisons of conventional hearing aids to implantable middle ear hearing devices should be performed when preparing a premarket approval application, according to an FDA 1draft guidance
Glans sheath devices
FDA proposed rule scheduled for publication in the May 10 Federal Register proposes that a premarket approval application or a notice of completion of a product development protocol be required for marketing of the preamendments product (21 CFR 884.5320). Comments on the proposal are due in 90 days
Can Organovo Leverage Its Solid Phase II Data In MASH?
Cash-limited Organovo has an FXR agonist showing competitive efficacy and tolerability in MASH, but may need a partner to move forward in that disease as it may be prioritizing its IBD program.